Literature DB >> 24452448

FDA acts to limit exposure to acetaminophen in combination products.

Michael McCarthy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24452448     DOI： 10.1136/bmj.g356

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.

Authors:  Tingting Yan; Hong Wang; Min Zhao; Tomoki Yagai; Yingying Chai; Kristopher W Krausz; Cen Xie; Xuefang Cheng; Jun Zhang; Yuan Che; Feiyan Li; Yuzheng Wu; Chad N Brocker; Frank J Gonzalez; Guangji Wang; Haiping Hao
Journal:  Drug Metab Dispos       Date:  2016-03-10       Impact factor: 3.922

2.  A Quality Improvement Project to Reduce Combination Acetaminophen-opioid Prescriptions to Pediatric Orthopedic Patients.

Authors:  Thomas J Caruso; Sunny Trivedi; Whitney Chadwick; Shabnam Gaskari; Ellen Wang; Juan Marquez; Sara Lagasse; Madison Bailey; Kevin Shea
Journal:  Pediatr Qual Saf       Date:  2020-04-28

3.  Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions.

Authors:  Bridget Kelly; Amie O'Donoghue; Sarah Parvanta; Vanessa Boudewyns; Oluwamurewa Oguntimein; Carla Bann; Sue West; Janice Tzeng; Caroline Chandler; Gabriel Madson; Lauren McCormack
Journal:  J Pharm Policy Pract       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.